Event Listings
NDD Europe 2019

Multiple clinical failures in the neurodegenerative field have sparked realisation that there is a critical need for discussion and debate between neurodegenerative drug developers to drive clinical success.

NDD Europe will overcome the translational challenges facing neurodegenerative drug developers by exploring the future biomarkers of neurodegeneration, improving preclinical modelling to increase clinical predictability and encouraging precompetitive strategies and collaboration amongst drug developers.

With 70+ thought-leaders converging at NDD Europe, this will be an unrivalled opportunity for you to gain the latest scientific insights, have your peers review your research and grow your collaborator network. Key talks form industry experts will address:

- Seeking blood-based biomarkers to advance patient stratification and diagnosis
- Assessing CSF-based and imaging biomarker techniques to improve biomarker translatability
- Exploring novel preclinical models for neurodegeneration to allow disease recapitulation
- Evaluating different approaches for targeting neurodegeneration and efficiently crossing the blood-brain barrier for drug delivery and target engagement

NDD Europe will provide a platform for creative thinking, encouraging debate and communication to enable the neurodegeneration field to shape their future research with reduced risk and greater efficiency.

Brochure https://go.evvnt.com/350845-0?pid=4870
Website https://go.evvnt.com/350845-2?pid=4870

Gold: Conference + 2 Workshops: EUR 3097.0,
Silver: Conference + 1 Workshop: EUR 2698.0,
Bronze: Conference Only: EUR 2299.0,
Workshop(s) Only: EUR 499.0

Speakers: Angel Cedazo-Minguez, Head of Neuroscience Research, Sanofi, Alastair D. Reith, Senior Director, External Innovation, GSK , Andy Takle, Executive Director and Head, Hatfield Research Laboratories, Neurology Business Group, Eisai, Carol Routledge, Director of Research, Alzheimer's Research UK , Gary Gilmour, Research Advisor, Translational and Integrative Neuroscience, Eli Lilly , Hugh Marston, Senior Research Fellow and Head of Translational Neuroscience, Eli Lilly , Jan Egebjerg Jensen, Senior Director, Neurodegeneration Discovery Biology, Janssen, Jan Torleif Pedersen, Director, Therapeutic Biology Lead, Alzheimer’s Disease and Dementia, Neuroscience, Lundbeck , Luc Ver Donck, Scientific Director, Head of Alzheimer Disease Animal Models, Neuroscience Discovery, Janssen , Mark Schmidt, Senior Director, Janssen , Nathalie Cartier-Lacave, Acting Chief Scientific Officer, BrainVectis, Patrick Downey, Director, Head of Neurodegeneration, UCB, Ralph Laufer, Chief Scientific Officer, Lysogene, Richard Wyse, Global Director of Research and Development, The Cure Parkinson's Trust, Ross Jeggo, Head of Research, Neuropsychiatry Centre for Therapeutic Innovation, Servier, Tania Nikolcheva, Principal Medical Director, Roche, Tauseef Butt, Chief Executive Officer, Progenra, Ulf Andreasson, Associate Professor, University of Gothenburg

Time: 10:00 am - 5:00 pm

Event Date: 21 May 2019 - 23 May 2019 Contact Person: Sophie Ellis
Venue: Hilton Paris La Defense, 2 Place de la Défense, Puteaux, 92800 Email:
Country: France Tel: 2031418700

Registration Website: https://go.evvnt.com/350845-1?pid=4870

Submitted by Love Evvnt, Evvnt on Tuesday, 21 May 2019 at 10:00 AM
Category: Health Care & Medical
Related News

Micro-hospitals Market to Witness Steady Expansion During 2018 - 2026
Thursday, 20 Jun 2019

Cardiac Equipment Market Size to Observe Steady Growth
Thursday, 20 Jun 2019

Powered Wheelchair Market Growth Opportunities & Technology Developments by 2027
Thursday, 20 Jun 2019

Sterility Indicators Market to be at Forefront by 2026
Thursday, 20 Jun 2019

Sacroiliac Fusion Implants Market Size, Share & Trend | Industry Analysis Report, 2027
Thursday, 20 Jun 2019

Related Events

Vestibular Schwannoma Conference 2019
Wednesday, 19 Jun 2019

2nd International Public Mental Health Conference
Wednesday, 19 Jun 2019

III World Congress and VI International Congress on Dual Disorders ICDD2019
Wednesday, 19 Jun 2019

8th Annual HPAPI Summit
Wednesday, 19 Jun 2019

World Congress on Thyroid Cancer 3.5
Thursday, 20 Jun 2019

Upcoming Events

Vestibular Schwannoma Conference 2019
Wednesday, 19 Jun 2019

Palo Alto Networks: May - Palo Alto Networks Heads-up
Wednesday, 19 Jun 2019

2nd International Public Mental Health Conference
Wednesday, 19 Jun 2019

III World Congress and VI International Congress on Dual Disorders ICDD2019
Wednesday, 19 Jun 2019

Hi And Fi Asia-China 2019
Wednesday, 19 Jun 2019

Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Friday, 21 June 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Consumer Technology
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
News & Media
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!

Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.

  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.

  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Latest Press Releases
  • Eye Makeup Concepts for a New Look
  • OSTARINE: Anything You Ever Wanted To know About MK-2866
  • What's clenbuterol?
  • WIMI Hologram AR is Dedicated to Internet Visual AI Cloud While MEGVII and SenseTime have Excellent
  • Ensure better charity cases with Finterra Waqf Chain

  • Latest Jobs
    Sorry, there are currently no entries posted here.